217 related articles for article (PubMed ID: 28333708)
1. Cost-effectiveness of Antihypertensive Medication: Exploring Race and Sex Differences Using Data From the REasons for Geographic and Racial Differences in Stroke Study.
Tajeu GS; Mennemeyer S; Menachemi N; Weech-Maldonado R; Kilgore M
Med Care; 2017 Jun; 55(6):552-560. PubMed ID: 28333708
[TBL] [Abstract][Full Text] [Related]
2. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.
Gu D; He J; Coxson PG; Rasmussen PW; Huang C; Thanataveerat A; Tzong KY; Xiong J; Wang M; Zhao D; Goldman L; Moran AE
PLoS Med; 2015 Aug; 12(8):e1001860. PubMed ID: 26241895
[TBL] [Abstract][Full Text] [Related]
3. Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling Study.
Vasudeva E; Moise N; Huang C; Mason A; Penko J; Goldman L; Coxson PG; Bibbins-Domingo K; Moran AE
Am J Hypertens; 2016 Oct; 29(10):1195-205. PubMed ID: 27172970
[TBL] [Abstract][Full Text] [Related]
4. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.
Moise N; Huang C; Rodgers A; Kohli-Lynch CN; Tzong KY; Coxson PG; Bibbins-Domingo K; Goldman L; Moran AE
Hypertension; 2016 Jul; 68(1):88-96. PubMed ID: 27181996
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops.
Bryant KB; Moran AE; Kazi DS; Zhang Y; Penko J; Ruiz-Negrón N; Coxson P; Blyler CA; Lynch K; Cohen LP; Tajeu GS; Fontil V; Moy NB; Ebinger JE; Rader F; Bibbins-Domingo K; Bellows BK
Circulation; 2021 Jun; 143(24):2384-2394. PubMed ID: 33855861
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece.
Maniadakis N; Ekman M; Fragoulakis V; Papagiannopoulou V; Yfantopoulos J
Eur J Health Econ; 2011 Jun; 12(3):253-61. PubMed ID: 20411401
[TBL] [Abstract][Full Text] [Related]
7. Does the Association of Diabetes With Stroke Risk Differ by Age, Race, and Sex? Results From the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
Malla G; Long DL; Judd SE; Irvin MR; Kissela BM; Lackland DT; Safford MM; Levine DA; Howard VJ; Howard G; Rhodes JD; Voeks JH; Kleindorfer DO; Anderson A; Meschia JF; Carson AP
Diabetes Care; 2019 Oct; 42(10):1966-1972. PubMed ID: 31391199
[TBL] [Abstract][Full Text] [Related]
8. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T
PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907
[TBL] [Abstract][Full Text] [Related]
9. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
[TBL] [Abstract][Full Text] [Related]
10. Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS Study.
Akinyelure OP; Jaeger BC; Safford MM; Oparil S; Carson AP; Sims A; Hannon L; Howard G; Muntner P; Hardy ST
J Am Heart Assoc; 2024 May; 13(10):e031695. PubMed ID: 38752519
[TBL] [Abstract][Full Text] [Related]
11. Sex and Race Differences in the Association of Incident Ischemic Stroke With Risk Factors.
Howard VJ; Madsen TE; Kleindorfer DO; Judd SE; Rhodes JD; Soliman EZ; Kissela BM; Safford MM; Moy CS; McClure LA; Howard G; Cushman M
JAMA Neurol; 2019 Feb; 76(2):179-186. PubMed ID: 30535250
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of hypertension therapy according to 2014 guidelines.
Moran AE; Odden MC; Thanataveerat A; Tzong KY; Rasmussen PW; Guzman D; Williams L; Bibbins-Domingo K; Coxson PG; Goldman L
N Engl J Med; 2015 Jan; 372(5):447-55. PubMed ID: 25629742
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.
Jönsson B; Carides GW; Burke TA; Dasbach EJ; Lindholm LH; Dahlöf B;
J Hypertens; 2005 Jul; 23(7):1425-31. PubMed ID: 15942467
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of antihypertensive drugs and treatment guidelines.
Kučan M; Lulić I; Pelčić JM; Mozetič V; Vitezić D
Eur J Clin Pharmacol; 2021 Nov; 77(11):1665-1672. PubMed ID: 34075437
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of antihypertensive triple combination therapy among patients enrolled in a Medicare advantage plan.
Wang X; Chen H; E E; Wu J; Serna O; Paranjpe R; Abughosh S
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):829-836. PubMed ID: 32703040
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation.
Hogan TJ; Elliott WJ; Seto AH; Bakris GL
Pharmacoeconomics; 2002; 20(1):37-47. PubMed ID: 11817991
[TBL] [Abstract][Full Text] [Related]
17. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
[TBL] [Abstract][Full Text] [Related]
18. Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study.
Langford AT; Akinyelure OP; Moore TL; Howard G; Min YI; Hillegass WB; Bress AP; Tajeu GS; Butler M; Jaeger BC; Yano Y; Shimbo D; Ogedegbe G; Calhoun D; Booth JN; Muntner P
Hypertension; 2020 Nov; 76(5):1600-1607. PubMed ID: 32924633
[TBL] [Abstract][Full Text] [Related]
19. Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Cushman WC; Reda DJ; Perry HM; Williams D; Abdellatif M; Materson BJ
Arch Intern Med; 2000 Mar; 160(6):825-31. PubMed ID: 10737282
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease.
Erickson KF; Japa S; Owens DK; Chertow GM; Garber AM; Goldhaber-Fiebert JD
J Am Coll Cardiol; 2013 Mar; 61(12):1250-8. PubMed ID: 23500327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
